Focused on your needs
A simple, unified Gollip offers adaptive and accessible solutions for patients
We at Gollip Pharma are committed to putting people at the center of what we do. By building on our strong global presence and harnessing our size and scale, we are increasing access to quality health solutions with the potential to enable millions of people around the world to live better, healthier days. We do this by striving to develop and produce affordable, high-quality generic drugs, innovative specialty pharmaceuticals, and active pharmaceutical ingredients.
It is our employees who are at the core of our success as a global pharmaceutical leader and the world’s largest generic medicines producer. We have colleagues in over 60 countries that develop, produce, and deliver the “world’s largest medicine cabinet” to 200 million people every day1.
By simplifying and unifying our business, we are working to meet the needs of our stakeholders and keep our promise to build a sustainable business. Our goal is to meet the current needs of patients and caregivers by continually developing our diverse portfolio of products and solutions, and we strive to anticipate future patient needs by evolving through research and development through key therapeutic areas, business development, and innovation.
We wake up with pride every morning knowing that we help people to live better days while ensuring the highest standards of compliance and business integrity in everything we do. This is how we improve health and enable people to live better, healthier lives.
This HIV Awareness Month, Teva is raising awareness of the impressive progress that has been made to prevent and improve health outcomes related to HIV/AIDS. Yet, we also recognize the need to continue supporting communities and patients, as well as increase access to treatment.
Pharmacovigilance is the process of collecting, monitoring, researching and evaluating information from healthcare providers and patients for the purposes of understanding and preventing drug-related problems. Alvogenʼs Global Quality Team is dedicated to the collection, monitoring, evaluation and reporting of safety information, through its global pharmacovigilance system.
Killam Pharma currently markets a portfolio of US brand name pharmaceutical products covering a wide range of therapeutic areas including: psychiatry, pain management, anti-infectives and cardiovascular related disorders.
Meet Our Management
Doug joined the Killam Pharma team after more than 33 years on the innovator/brand side of the pharmaceutical industry.